>
Vita Life Sciences logo

VLS - Vita Life Sciences Share Price

A$1.02 0.0  0.0%

Last Trade - 13/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £30.4m
Enterprise Value £23.4m
Revenue £25.6m
Position in Universe 1087th / 1913
Bullish
Bearish
Unlock VLS Revenue
Momentum
Relative Strength (%)
1m -8.43%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
38.6 37.8 37.2 41.2 42.5 46.5 +3.8%
-40.3 -23.2 -3.1 -23.0 +30.0 +103.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, VitaLife Sciences Limited revenues increased 9% to A$46.5M. Netincome increased 94% to A$6.1M. Revenues reflect Australiasegment increase of 25% to A$20.8M, Malaysia segmentincrease of 8% to A$16.9M. Net income benefited fromMarketing expenses decrease of 36% to A$2.2M (expense),Other Income increase from A$36K to A$645K (income).Dividend per share remained flat at A$0.04.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VLS Revenue Unlock VLS Revenue

Net Income

VLS Net Income Unlock VLS Revenue

Normalised EPS

VLS Normalised EPS Unlock VLS Revenue

PE Ratio Range

VLS PE Ratio Range Unlock VLS Revenue

Dividend Yield Range

VLS Dividend Yield Range Unlock VLS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
VLS EPS Forecasts Unlock VLS Revenue
Profile Summary

Vita Life Sciences Limited (Vita Life) is a healthcare company. The Company is involved in the formulating, packaging, sales and distribution of vitamins and supplements. The Company's segments include health, including sale of vitamins and supplements, and investment, including general investments. It offers products under the brands, such as Vita Health, Herbs of Gold and VitaScience, throughout the Asia-Pacific region. The Company has presence in Australia, Singapore, Malaysia and others. The Company's over the counter (OTC) products are mainly sold at pharmacies and health food stores. Its subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed BioSciences Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, Herbs of Gold (Shanghai) Co. Limited, Vita Life Science (S) Pte Limited and Sino Metro Developments Limited.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated November 5, 1986
Public Since August 24, 2007
No. of Shareholders: 795
No. of Employees: 124
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 54,082,612
Free Float (0.0%)
Eligible for
ISAs
SIPPs
VLS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VLS
Upcoming Events for VLS
Friday 23rd July, 2021 Estimate
Vita Life Sciences Ltd Annual Shareholders Meeting
Frequently Asked Questions for Vita Life Sciences
What is the Vita Life Sciences share price?

As of 13/05/21, shares in Vita Life Sciences are trading at A$1.02, giving the company a market capitalisation of £30.4m. This share price information is delayed by 15 minutes.

How has the Vita Life Sciences share price performed this year?

Shares in Vita Life Sciences are currently trading at A$1.02 and the price has moved by 80.53% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Vita Life Sciences price has moved by 38.28% over the past year.

What are the analyst and broker recommendations for Vita Life Sciences?

Of the analysts with advisory recommendations for Vita Life Sciences, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Vita Life Sciences is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Vita Life Sciences next release its financial results?

Vita Life Sciences is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Vita Life Sciences dividend yield?

The Vita Life Sciences dividend yield is 4.17% based on the trailing twelve month period.

Does Vita Life Sciences pay a dividend?

Last year, Vita Life Sciences paid a total dividend of 0.04, and it currently has a trailing dividend yield of 4.17%. Looking ahead, Vita Life Sciences has not announced an ex-dividend date yet.

When does Vita Life Sciences next pay dividends?

Vita Life Sciences has yet to annouce their ex-dividend date. The historic dividend yield on Vita Life Sciences shares is currently 4.17%.

How do I buy Vita Life Sciences shares?

To buy shares in Vita Life Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Vita Life Sciences?

Shares in Vita Life Sciences are currently trading at A$1.02, giving the company a market capitalisation of £30.4m.

Where are Vita Life Sciences shares listed? Where are Vita Life Sciences shares listed?

Here are the trading details for Vita Life Sciences:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: VLS
What kind of share is Vita Life Sciences?

Based on an overall assessment of its quality, value and momentum, Vita Life Sciences is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Vita Life Sciences share price forecast 2021?

We were not able to load any forecast data for Vita Life Sciences.

How can I tell whether the Vita Life Sciences share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vita Life Sciences. Over the past six months, the relative strength of its shares against the market has been 7.45%. At the current price of A$1.02, shares in Vita Life Sciences are trading at 17.76% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Vita Life Sciences PE Ratio?

The Vita Life Sciences PE ratio based on its reported earnings over the past 12 months is 8.78. The shares are currently trading at A$1.02.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Vita Life Sciences?

Vita Life Sciences's management team is headed by:

Lim Sung Tie - CEO
Chin Khoo - CFO
Edmund Sim - GMG
Jonathan Tooth - NED
Tanakorn Chalermjiripas - GMG
Shane Teoh - NED
Andrew O'Keefe - MDR
Gregory Ralph - NED
Who are the major shareholders of Vita Life Sciences?

Here are the top five shareholders of Vita Life Sciences based on the size of their shareholding:

Chemical Investments Ltd Corporation
Percentage owned: 15.81% (8.55m shares)
Teoh (Shane) Individual Investor
Percentage owned: 15.6% (8.44m shares)
Barings Acceptance Ltd. Corporation
Percentage owned: 13.63% (7.37m shares)
Anglo Australian Christian and Charitable Fund Corporation
Percentage owned: 11.6% (6.28m shares)
Tie (Lim Sung Eddie) Individual Investor
Percentage owned: 9.98% (5.40m shares)
Similar to VLS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.